The COVID-19 pandemic and upgrades of CI speech processors for children: part II–hearing outcomes

PURPOSE: To gauge the benefits to children of upgrading speech processors during the COVID-19 pandemic. METHODS: The study involved 297 children, aged from 7.3 to 18.0 years, whose processors were upgraded to either Nucleus 7 or Kanso 2, or to Sonnet 2 or Rondo 3. To document the benefits of the upg...

Descripción completa

Detalles Bibliográficos
Autores principales: Obrycka, Anita, Lorens, Artur, Walkowiak, Adam, Wlodarczyk, Elzbieta, Dziendziel, Beata, Skarzynski, Piotr Henryk, Skarzynski, Henryk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Otology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919915/
https://www.ncbi.nlm.nih.gov/pubmed/35286441
http://dx.doi.org/10.1007/s00405-022-07324-8
Descripción
Sumario:PURPOSE: To gauge the benefits to children of upgrading speech processors during the COVID-19 pandemic. METHODS: The study involved 297 children, aged from 7.3 to 18.0 years, whose processors were upgraded to either Nucleus 7 or Kanso 2, or to Sonnet 2 or Rondo 3. To document the benefits of the upgrades, a speech-in-noise discrimination test and Patient Reported Outcome Measures (PROMs) were used. RESULTS: There was a significant benefit from the newer processors in terms of speech discrimination in noise. Patient Reported Outcome Measures (PROMs) indicated less hearing disability, a higher level of functioning in everyday life situations, and more satisfaction with the new speech processor in social situations. CONCLUSION: There is a measurable improvement in performance when the devices are upgraded to the new technology.

Ejemplares similares